Vermersch, P., Eralinna, J., Nicholas, R., Oreja-Guevara, C., Siva, A., Van Wijmeersch, B., . . . Comi, G. (2019). Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1‑year interim results). Journal of the neurological sciences, 405, 310. https://doi.org/10.1016/j.jns.2019.10.1404
Citace podle Chicago (17th ed.)Vermersch, P., et al. "Efficacy and Safety of Ocrelizumab in Patients with Relapsing-remitting Multiple Sclerosis with a Suboptimal Response to Previous Disease-modifying Therapies (1‑year Interim Results)." Journal of the Neurological Sciences 405 (2019): 310. https://doi.org/10.1016/j.jns.2019.10.1404.
Citace podle MLA (9th ed.)Vermersch, P., et al. "Efficacy and Safety of Ocrelizumab in Patients with Relapsing-remitting Multiple Sclerosis with a Suboptimal Response to Previous Disease-modifying Therapies (1‑year Interim Results)." Journal of the Neurological Sciences, vol. 405, 2019, p. 310, https://doi.org/10.1016/j.jns.2019.10.1404.